Table 5 Hospital length of stay and waiting period for transfer in the survived patients.
From: Fluid restriction management in the treatment of COVID-19: a single-center observational study
Group 1 (N = 48) | Group 2 (N = 36) | Group 3 (N = 17) | P value | |
---|---|---|---|---|
MV duration | 5 (4–7) | 12 (9–14) | < 0.001 | |
ECMO duration | 7 (6–10) | N/A | ||
Hospital LOS | 4.5 (2–7) | 9 (7–15) | 18 (12–26) | < 0.001 |
Waiting days | 2 (1–3.5) | 3 (1–7) | 0.33 |